Cargando…

Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo

BACKGROUND: The cellular prion protein (PrP(C)) fulfils several yet not completely understood physiological functions. Apart from these functions, it has the ability to misfold into a pathogenic scrapie form (PrP(Sc)) leading to fatal transmissible spongiform encephalopathies. Proteolytic processing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altmeppen, Hermann C, Prox, Johannes, Puig, Berta, Kluth, Mark A, Bernreuther, Christian, Thurm, Dana, Jorissen, Ellen, Petrowitz, Bettina, Bartsch, Udo, De Strooper, Bart, Saftig, Paul, Glatzel, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224557/ https://www.ncbi.nlm.nih.gov/pubmed/21619641 http://dx.doi.org/10.1186/1750-1326-6-36

Ejemplares similares

The sheddase ADAM10 is a potent modulator of prion disease
por: Altmeppen, Hermann C, et al.
Publicado: (2015)

Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein
por: Linsenmeier, Luise, et al.
Publicado: (2018)

Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein
por: Mohammadi, Behnam, et al.
Publicado: (2022)

Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17
por: Yang, Guang, et al.
Publicado: (2021)

The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016)

Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
por: Matamoros-Angles, Andreu, et al.
Publicado: (2023)

Deficiency of the Metalloproteinase-Disintegrin ADAM8 Is Associated with Thymic Hyper-Cellularity
por: Gossens, Klaus, et al.
Publicado: (2010)

A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma
por: Kanzaki, Hiroyuki, et al.
Publicado: (2016)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12
por: Qi, Yue, et al.
Publicado: (2014)

A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2022)

GPI-anchor signal sequence influences PrP(C) sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice
por: Puig, Berta, et al.
Publicado: (2019)

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers()
por: Burdelski, Christoph, et al.
Publicado: (2017)

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase Protein 8 (ADAM 8) in Autism Spectrum Disorder: Links to Neuroinflammation
por: Al-Ayadhi, Laila, et al.
Publicado: (2023)

Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
por: Chalaris, Athena, et al.
Publicado: (2010)

The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor
por: Atfi, Azeddine, et al.
Publicado: (2007)

A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development
por: Toonen, Joseph A., et al.
Publicado: (2016)

A Novel Pro-Inflammatory Mechanosensing Pathway Orchestrated by the Disintegrin Metalloproteinase ADAM15 in Synovial Fibroblasts
por: Janczi, Tomasz, et al.
Publicado: (2021)

Potential role of a disintegrin and metalloproteinase-17 (ADAM17) in age-associated ventricular remodeling of rats
por: Liu, Hainiang, et al.
Publicado: (2019)

Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy
por: Moriwaki, Michika, et al.
Publicado: (2022)

A Disintegrin and Metalloproteinase 10 (ADAM10) Is Essential for Oligodendrocyte Precursor Development and Myelination in the Mouse Brain
por: Guo, Dazhi, et al.
Publicado: (2022)

Role of ADAMs in the Ectodomain Shedding and Conformational Conversion of the Prion Protein
por: Taylor, David R., et al.
Publicado: (2009)

A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation
por: Yang, Xiaoyuan, et al.
Publicado: (2018)

N-Glycans and Glycosylphosphatidylinositol-Anchor Act on Polarized Sorting of Mouse PrP(C) in Madin-Darby Canine Kidney Cells
por: Puig, Berta, et al.
Publicado: (2011)

ADAM-15 Disintegrin-Like Domain Structure and Function
por: Lu, Dong, et al.
Publicado: (2010)

A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
por: Giebeler, Nives, et al.
Publicado: (2016)

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
por: Sahin, Umut, et al.
Publicado: (2004)

MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9)
por: Liu, Ruibao, et al.
Publicado: (2018)

Cytoplasmic Relaxation of Active Eph Controls Ephrin Shedding by ADAM10
por: Janes, Peter W., et al.
Publicado: (2009)

A disintegrin and metalloprotease 10 (ADAM10) is a central regulator of murine liver tissue homeostasis
por: Müller, Miryam, et al.
Publicado: (2016)

A Disintegrin and Metalloproteases (ADAMs): Activation, Regulation and Mechanisms of Catalysis
por: Maretzky, Thorsten
Publicado: (2021)

A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection
por: Bazzone, Lindsey E., et al.
Publicado: (2019)

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
por: Oh, Sooyeon, et al.
Publicado: (2020)

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
por: Shafiq, Mohsin, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase 9 Is Involved in Ectodomain Shedding of Receptor-Binding Cancer Antigen Expressed on SiSo Cells
por: Sonoda, Kenzo, et al.
Publicado: (2014)

Disordered structure and flexible roles: using the prion protein N1 fragment for neuroprotective and regenerative therapy
por: Mohammadi, Behnam, et al.
Publicado: (2020)

Epigenetic Regulation of a Disintegrin and Metalloproteinase (ADAM) Transcription in Colorectal Cancer Cells: Involvement of β-Catenin, BRG1, and KDM4
por: Sun, Lina, et al.
Publicado: (2020)

Relationship Between Proteinase with a Disintegrin and a Metalloproteinase Domain-9 (ADAM9), Inflammation, Airway Remodeling, and Emphysema in COPD Patients
por: Cui, Liwei, et al.
Publicado: (2020)

The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family
por: Kelwick, Richard, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dhqs6dt2b9bnhhb1f0vlm0fc2u